NCT01748487View on ClinicalTrials.gov

The Effect of Intravitreal Ozurdex on DME After Cataract Surgery

PHASE3CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

September 30, 2015

Study Completion Date

September 30, 2015

Conditions
Diabetic Macular Edema
Interventions
DRUG

dexamethasone intravitreal implant (OZURDEX)

intravitreal implant

Trial Locations (1)

M5T2S8

UHN, Toronto Western Hospital, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER

NCT01748487 - The Effect of Intravitreal Ozurdex on DME After Cataract Surgery | Biotech Hunter | Biotech Hunter